Amoxicillin / clavulanate (oral)
Orals / systemic · Rx
RxOrals / systemicPenicillinPreservative-free option
| Strength | 250/125 mg, 500/125 mg, 875/125 mg tablets; oral suspension |
|---|---|
| Drug class | Penicillin + beta-lactamase inhibitor, systemic |
| Mechanism of action | Amoxicillin inhibits bacterial cell-wall synthesis; clavulanate is a beta-lactamase inhibitor that extends coverage to beta-lactamase-producing Staph aureus, H. influenzae and other otherwise-resistant organisms. |
| Indication / reason for use | First-line oral cover for preseptal cellulitis and an infected internal hordeolum / chalazion (Staph aureus, Strep, H. influenzae); dacryocystitis; adjunct for lid-margin infections. |
| Usual adult dosing | Adults: 875/125 mg PO twice daily (or 500/125 mg three times daily) for 7-10 days. Reassess at 48 h; refer urgently if post-septal (orbital) signs develop. |
| Preservative | N/A (oral) , a preservative-free option exists |
| Contact lenses | No direct lens interaction. |
| Common / important adverse effects | GI upset and diarrhea (more than amoxicillin alone), rash, candidiasis; rare cholestatic hepatitis, more common in older adults and with longer courses. |
| Contraindications & cautions | Penicillin / beta-lactam allergy; prior amoxicillin-clavulanate-associated cholestatic jaundice or hepatic dysfunction; avoid in infectious mononucleosis (rash risk). |
| Pregnancy / lactation | Considered safe in pregnancy and lactation; first-line where a systemic antibiotic is needed and there is no penicillin allergy. |
| Pregnancy category (older labels) | Category B on the label (the FDA retired letter categories in 2015). From DailyMed labels, checked Nov 2026. |
| Trade names | Augmentin |
| Practice notes | Preferred first-line over doxycycline for preseptal cellulitis given its pregnancy and pediatric safety; reserve doxycycline for penicillin allergy, MRSA risk, or lid/surface disease that benefits from its anti-inflammatory effect. |
Chair-side reference only. Dosing, contraindications and pregnancy guidance here are not exhaustive. Confirm against the current prescribing information and the patient’s full history before prescribing or advising.